ReCode Therapeutics
ReCode Therapeutics

ReCode Therapeutics Information

Contact top employees from ReCode Therapeutics

Summary

ReCode Therapeutics is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by David J. Lockhart. Its headquarters is located at Menlo Park, California, USA. The number of employees ranges from 1 to 25. The annual revenue of ReCode Therapeutics varies between 100K and 5.0M. Total funding of the company - $82M. To connect with ReCode Therapeutics employee register on SignalHire.

Organization Website

recodetx.com

Social Links

linkedIntwitter

Phone Number

408-585-1700

Industries

Headquarters Location

Menlo Park, California & Durham, North Carolina, US

Employees Size

10-50 employees

Specialties

RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, Biotechnology

DMA Code

San Francisco Bay Area

Founded

2015

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2018Privately
Held
1 - 25 6M $109.5M
2018Privately
Held
1 - 25 < 1M $534M
2016Privately
Held
25 - 100 2M $219.6M
2011Privately
Held
25 - 100 16M $20.2M

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at ReCode Therapeutics shows a diverse range of experience levels:
3% have been with the company for less than 1 year42% for 1–2 years30% for 3–4 years15% for 5–7 years9% for 8–10 years
Ex-employees positions
In Company
In New Company
Contact top employees from ReCode Therapeutics

FAQ

ReCode Therapeutics operates in the Biotech industries. More details can be found on the official website: recodetx.com.
The headquarters of ReCode Therapeutics are located in Menlo Park, California & Durham, North Carolina, United States.
The current CEO of ReCode Therapeutics is David J. Lockhart
You can contact ReCode Therapeutics by phone at 408-585-1700.
ReCode Therapeutics currently employs 10-50 people.
ReCode Therapeutics's revenue is approximately 4.1M.
Well-known competitors of ReCode Therapeutics include Aro Biotherapeutics, Day One Biopharmaceuticals, Parabilis Medicines and Halo Labs.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP